phosphotyrosine has been researched along with uridine triphosphate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Boarder, MR; Bowden, A; Brown, CA; Patel, V | 1 |
| de Widt, J; Divecha, N; van Baal, J; van Blitterswijk, WJ | 1 |
| Krasovska, V; Reynolds, KE; Scott, AL | 1 |
3 other study(ies) available for phosphotyrosine and uridine triphosphate
| Article | Year |
|---|---|
Stimulation of prostacyclin release by endothelial ATP receptors requires activation of protein kinase C and tyrosine kinases.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Triphosphate; Animals; Aorta; Blotting, Western; Cattle; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Thionucleotides; Uridine Triphosphate | 1996 |
Diacylglycerol kinase θ counteracts protein kinase C-mediated inactivation of the EGF receptor.
Topics: Bradykinin; Cell Line, Tumor; Cell Membrane; Diacylglycerol Kinase; Endosomes; Enzyme Activation; ErbB Receptors; Gene Silencing; Green Fluorescent Proteins; HEK293 Cells; Humans; Phosphorylation; Phosphothreonine; Phosphotyrosine; Protein Binding; Protein Kinase C; Protein Transport; Tetradecanoylphorbol Acetate; Uridine Triphosphate | 2012 |
Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3.
Topics: Animals; Astrocytes; Cells, Cultured; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Interleukin-6; Male; Mice; Mice, Knockout; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Purinergic P2Y Receptor Agonists; Receptors, Interleukin-6; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Sulfonamides; Tenascin; Toll-Like Receptor 4; Uridine Triphosphate | 2021 |